Enterobacter infections caused

The sulfonamides are often used to control urinary tract infections caused by certain bacteria such as Escherichia coli, Staphylococcus aureus, and Klebsiella-Enterobacter. Mafenide (Sulfamylon) and silver sulfadiazine (Silvadene) are topical sulfonamides used in the treatment of second- and third-degree bums. Additional uses of the sulfonamides are given in the Summary Drug Table The Sulfonamides. 

Complicated intra-abdominal infections- In combination with metronidazole for complicated intra-abdominal infections caused by E. coll, viridans group streptococci, P. aeruginosa, K. pneumoniae, Enterobacter sp., or B. fragilis. 

Skin and skin structure infections- Skin and skin structure infections, including abscesses, cellulitis, infected skin ulcers, and wound infections caused by S. aureus (including penicillinase-producing strains) Streptococcus pyogenes, group D streptococcus including . faecalis, Acinetobacter sp. including iA. calcoaceticus] Citrobactersp.] E. coli] Enterobacter cloacae, K. pneumoniae]... 

May be effective in the treatment of acute urinary tract infections caused by susceptible strains of gram-positive and gram-negative bacteria, especially Enterobacter sp. and Escherichia coii. It usually is less effective than other antimicrobial agents in the treatment of urinary tract infections caused by bacteria other than mycobacteria. Consider using only when the more conventional therapy has failed and when the organism has demonstrated sensitivity. 

Used in all types of infection caused by Salmonella typhi, Klebsiella, Enterobacter, Pneumocystis carinii etc. and many other sulfonamide resistant stains of S. aureus, Strep, pyogenes, Shigella, E. coli, H. influenzae, meningococci and gonococci etc. It is particularly effective as a second line agent in penicillin allergic patients and also in patients where newer antibiotics are contraindicated or can t be used. 

Other infections caused by E. coli, K. pneumoniae, Enterobacter, Salmonella typhi, N. gonorrhoeae, N. meningitidis, H. influenzae, H. ducreyi, Shilgella, Vibrio cholerae. Pseudomonas aeruginosa. Staph, aureus etc. 

Urinary tract infection Caused by susceptible strains of Klebsiella sp., Enterobacter sp.. Strep, faecalis and other organisms. 

Pseudomonas bacteremia has been attributed to the use of material in open-heart surgery that was stored in accidentally contaminated benzalkonium solutions, and after cardiac catheterization caused by inadequate disinfection of the catheters with benzalkonium solutions. In 1961, about 15 patients were reported with Pseudomonas infections caused by cotton pledgets kept in a contaminated aqueous solution used for skin antisepsis before intravenous and intramuscular injection (8). In 1976 there were outbreaks of Pseudomonas cepacia infections in two American general hospitals (9) and pseudobacteremia Pseudomonas cepacia or Enterobacter) caused by contamination of blood cultures in 79 patients in whom contaminated aqueous benzalkonium solutions were used for skin and antisepsis before venepuncture and due to contamination of the samples (SEDA-11, 490) (10). 

Kanamycin can be used for short-term treatment of severe infections caused by susceptible strains (for example Escherichia coli, Proteus species, Enterobacter aerogenes, Klebsiella pneumoniae, Serratia marcescens, and Mima-Elerellea) that are resistant to other less ototoxic aminoglycosides. It is not indicated for long-term therapy, for example in tuberculosis. 

Lomefloxacin, a fluoroquinolone broad-spectrum antibiotic (400 mg p.o. daily for 10 to 14 days), is used in acute bacterial exacerbations of chronic bronchitis caused by Haemophilis influenzae or Moraxella (Branhamella) catarrhalis in uncomphcated urinary tract infections (cystitis) caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, or Staphylococcus saprophyticus, in complicated urinary tract infections caused by E. coli, K. pneumoniae, P. mirabilis, and Pseudomonas aeruginosa and it is possibly effective against infections caused by Citrobacter diversus or Enterobacter cloacae and for the prophylaxis of infections after transurethral surgical procedures (see also Figure 85). 

Imipenem-cilastatin is effective for a wide variety of infections, including urinary tract and lower respiratory infections intra-abdominal and gynecological infections and skin, soft tissue, bone, and joint infections. The drug combination appears to be especially useful for the treatment of infections caused by cephalosporin-resistant nosocomial bacteria, such as Citrobacter freundii and Enterobacter spp. It would be prudent to use imipenem for empirical treatment of serious infections in hospitalized patients who have recently received other P-lactam antibiotics because of the increased risk of infection with cephalosporin- and/or penicillin-resistant bacteria. Imipenem should not be used as monotherapy for infections owing to P. aeruginosa because of the risk of resistance developing during therapy. 

Urinary tract infections caused by susceptible E. coli, P. mirabilis, the indole-positive Proteus sp., Morganella morganii, Klebsiella sp., Enterobacter sp., Serratia sp.. Pseudomonas sp., S. faecalis (enterococcus)... 

Polymyxin B may be indicated (when less toxic drugs are ineffective or contraindicated) in serious infections caused by susceptible strains of the following organisms Haemophilus influenzae (meningeal infections) Escherichia coli (urinary tract infections) Enterobacter aero-genes (bacteremia) Klebsiella pneumoniae (bacteremia). In meningeal infections, polymyxin B sulfate must be administered only intrathecally. 

Ticarcillin, extended-spectrum penicillin, alpha-carbox-ypenicillin, is indicated for the treatment of bacterial septicemia, skin and soft-tissue infections, acute and chronic respiratory tract infections caused by susceptible strains of Pseudomonas aeruginosa, Proteus species (both indole-positive and indole-negative), and Escherichia coli and for genitourinary tract infections (complicated and uncomplicated) due to susceptible strains of P. aeruginosa, Proteus species (both indole-positive and indole-negative), E. coli, Enterobacter, and Streptococcus faecalis (enterococcus). 

In US the use of kanamycin is normally restricted to the infections related to the intestinal tract, such as bacillary dysentry systemic infections caused due to Gram-negative bacili, such as Klebsiella, Proteus, Enterobacter, and Serratia spp., which have developed resistance to some other antibiotics. It... 

---